Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion type Assertion NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_head.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion description "[Thus, P1465-hydroxylated Rpb1 and PHD1 represent attractive drug targets for new RCC treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_provenance.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion evidence source_evidence_literature NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_provenance.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion SIO_000772 20978146 NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_provenance.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion wasDerivedFrom befree-20150227 NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_provenance.
- NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_assertion wasGeneratedBy ECO_0000203 NP963367.RAaYwbV7xB2qPaSmJfBoiu7SovQj15IyV3RPHw3KpRJLY130_provenance.